
Dhanwantri Formulation Private Limited
About Dhanwantri Formulation Private Limited
Data last updated:
Dhanwantri Formulation Private Limited is a private limited company based in Patna, Bihar, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 28 September 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U51909BR2010PTC016140. Its GSTIN is 10AADCD8804H1Z1 (Bihar).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Abhay Kumar Manav (Managing Director) and Madhuri Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Patna, Bihar.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.55 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net loss of ₹1.11 Lakh (net margin -6.7%) and EBITDA of -₹1.08 Lakh (EBITDA margin -6.5%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Dhanwantri Formulation Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Abhay Kumar Manav Chanakya Nagar Near Tapovan Residential School Kumhara, R, Patna, Bihar, India – 800026
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Dhanwantri Formulation Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dhanwantri Formulation is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Dhanwantri Formulation Private Limited, buy the company report.
Financials of Dhanwantri Formulation Private Limited
FY 2025 filings availableDhanwantri Formulation Private Limited reported revenue of ₹16.55 Lakh (down 6% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 6% fall in the latest year. EBITDA fell 363% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.08 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.11 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.5% | ||||
| Net Profit Margin | -6.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dhanwantri Formulation Private Limited, buy the company report.
Board of directors of Dhanwantri Formulation Private Limited
Dhanwantri Formulation has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhay Kumar Manav | Managing Director | 28 Sep 2010 | 16 Years 1 Months | Current |
| Madhuri Kumari | Director | 28 Sep 2010 | 16 Years 1 Months | Current |
Peer comparison
Dhanwantri Formulation Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Usas Natural and Herbal Products Private Limited | ₹16.57 Lakh (FY 2025) | 6.0% | Palampur, Himachal Pradesh, India | |||
| Lucrative Tube & Tin Private Limited | ₹16.56 Lakh (FY 2019) | Bhiwadi, Rajasthan, India | ||||
| Napsko Healthcare Private Limited | ₹16.56 Lakh (FY 2024) | -46.0% | New Delhi, Delhi, India | |||
| Mojobox Retail Private Limited | ₹16.56 Lakh (FY 2024) | 112.0% | Bokaro, Jharkhand, India | |||
| Sai-Vatika Organics Private Limited | ₹16.56 Lakh (FY 2024) | 10.0% | Gondal, Gujarat, India | |||
| Dhanwantri Formulation Private Limitedthis company | ₹16.55 Lakh (FY 2024) | -₹1.11 Lakh | -6.7% | -6.0% | Patna, Bihar, India | |
| Advay Organics Solutions (OPC) Private Limited | ₹16.55 Lakh (FY 2025) | -18.0% | Hassan, Karnataka, India | |||
| Aspa Drugs Private Limited | ₹16.55 Lakh (FY 2025) | -13.0% | New Delhi, Delhi, India | |||
| Milestone Shoes Private Limited | ₹16.54 Lakh (FY 2025) | 10134.0% | Kolkata, West Bengal, India | |||
| Blaze Proof Systems Private Limited | ₹16.54 Lakh (FY 2024) | -78.0% | Delhi, India | |||
| Premium Broadcast Private Limited | ₹16.54 Lakh (FY 2024) | -66.0% | New Delhi, Delhi, India |
To see the full peer comparison of Dhanwantri Formulation Private Limited, buy the company report.
Auditor
Dhanwantri Formulation Private Limited is audited by B. K. PANDEY & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B. K. PANDEY & CO. | FY 2017 | 010480C |
Shareholding
The shareholding of Dhanwantri Formulation Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Dhanwantri Formulation Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dhanwantri Formulation Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dhanwantri Formulation Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dhanwantri Formulation has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AADCD8804H1Z1 | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dhanwantri Formulation Private Limited, buy the company report.
Recent activity
Dhanwantri Formulation Private Limited has 3 board changes on record since 2010: 2 appointments and 1 cessation. The latest: Manish Kumar ceased to be Director on 10 Aug 2018.
Frequently asked questions
Dhanwantri Formulation is an active private limited company based in Patna, Bihar, India. The company works in chemical products, within the chemicals industry. It was incorporated on 28 September 2010 (16+ years old) and is registered under CIN U51909BR2010PTC016140.
Dhanwantri Formulation has 2 current directors:
- Abhay Kumar Manav - Managing Director
- Madhuri Kumari - Director
The latest financial statements of Dhanwantri Formulation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dhanwantri Formulation is 10AADCD8804H1Z1, registered in Bihar.
The CIN (Corporate Identification Number) of Dhanwantri Formulation is U51909BR2010PTC016140. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dhanwantri Formulation was incorporated on 28 September 2010, making it 16+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Dhanwantri Formulation by revenue are Usas Natural and Herbal Products Private Limited, Lucrative Tube & Tin Private Limited, Napsko Healthcare Private Limited, Mojobox Retail Private Limited, Sai-Vatika Organics Private Limited and 5 more, all in the same principal business activity (retail trading).
Manish Kumar ceased to be Director on 10 Aug 2018. Abhay Kumar Manav was appointed as Managing Director on 28 Sep 2010. Madhuri Kumari was appointed as Director on 28 Sep 2010.
The registered office of Dhanwantri Formulation is at CO Abhay Kumar Manav Chanakya Nagar Near Tapovan Residential School Kumhara, R, Patna, Bihar, India – 800026.
Dhanwantri Formulation operates in the chemicals industry, in the chemical products segment.
The compliance status of Dhanwantri Formulation is compliant as of 16 August 2026. The company is actively filing with the Registrar of Companies.

